active
ACTIVE SINCE: 2021

Bristol Myers Squibb Foundation: Cancer Disparities in the Era of COVID19

Improving early diagnosis of lung cancer and expedite access to providers at specialty cancer hospitals.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
Pharma Company Foundation 1
Hospitals Health Facilities 1

Irmandade Santa Casa de Porto Alegre will integrate specialized health care in oncology with primary health care through two complementary digital health strategies: teleconsultation and patient navigation.

The overall goals of the project are to improve early diagnosis of lung cancer and expedite access to providers at specialty cancer hospitals.

Results and milestones
  • Parameters for the digital platform “just miine” are complete
  • Total of 68 primary care profressionals trained to follow and navigate patients using the digital platforms
  • All screened patients, total of 49, were referred to access to care according to the clinical recommendation based on the tomography result and the needs presented
Geographic Reach
  • Americas
See Where
Disease Area
  • Non-communicable Diseases
See Disease Areas
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
  1. 3.4: NCDs (including mental health)
  2. 3.8: Achieve universal health coverage
SDG 17: Partnerships for the Goals 
Partner organizations
Pharma Company Foundation

Bristol Myers Squibb Foundation

Hospitals Health Facilities

Irmandade Santa Casa de Porto Alegre